Natural Killer Cell Adoptive Transfer Therapy Exploiting the First Line of Defense Against Cancer

被引:98
作者
Davis, Zachary B. [1 ]
Felices, Martin [1 ]
Verneris, Michael R. [1 ]
Miller, Jeffrey S. [1 ]
机构
[1] Univ Minnesota, Dept Pediat, Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
关键词
Adoptive transfer therapy; antitumor functions; natural killer (NK) cells; prospective therapeutic enhancements; tumor microenvironment; RELAPSED/REFRACTORY MULTIPLE-MYELOMA; APOPTOSIS-INDUCING LIGAND; KIR ANTIBODY IPH2101; REGULATORY T-CELLS; HUMAN NK CELLS; MHC CLASS-I; TUMOR-CELLS; CYTOMEGALOVIRUS REACTIVATION; MATRIX METALLOPROTEINASES; SURFACE EXPRESSION;
D O I
10.1097/PPO.0000000000000156
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Natural killer (NK) cells constitute an important component of the initial immunological response against transformed cells. However, chronic exposure to the tumor microenvironment can fundamentally alter the ability of NK cells to sufficiently control tumor progression. Thus, the adoptive transfer of healthy, functional NK cells as an interventional therapy has been an area of great interest for improving patient outcomes. Recent developments in the field have provided a better understanding of what makes the NK compartment effective against malignant cells. Moreover, there are now multiple potential sources of NK cell products for infusion as well as techniques to manipulate these cells to enhance their antitumor functions. This review explores the advantages and disadvantages of various sources of NK cells as well as prospective therapeutic enhancements to adoptively transferred NK cells.
引用
收藏
页码:486 / 491
页数:6
相关论文
共 82 条
[21]  
Farag SS, 2004, ADV PHARMACOL, V51, P295
[22]  
FERRINI S, 1992, INT J CANCER, P15
[23]   The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT) [J].
Foley, Bree ;
Felices, Martin ;
Cichocki, Frank ;
Cooley, Sarah ;
Verneris, Michael R. ;
Miller, Jeffrey S. .
IMMUNOLOGICAL REVIEWS, 2014, 258 (01) :45-63
[24]   Human Cytomegalovirus (CMV)-Induced Memory-like NKG2C+ NK Cells Are Transplantable and Expand In Vivo in Response to Recipient CMV Antigen [J].
Foley, Bree ;
Cooley, Sarah ;
Verneris, Michael R. ;
Curtsinger, Julie ;
Luo, Xianghua ;
Waller, Edmund K. ;
Anasetti, Claudio ;
Weisdorf, Daniel ;
Miller, Jeffrey S. .
JOURNAL OF IMMUNOLOGY, 2012, 189 (10) :5082-5088
[25]   Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function [J].
Foley, Bree ;
Cooley, Sarah ;
Verneris, Michael R. ;
Pitt, Michelle ;
Curtsinger, Julie ;
Luo, Xianghua ;
Lopez-Verges, Sandra ;
Lanier, Lewis L. ;
Weisdorf, Daniel ;
Miller, Jeffrey S. .
BLOOD, 2012, 119 (11) :2665-2674
[26]   CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner [J].
Ghiringhelli, F ;
Ménard, C ;
Terme, M ;
Flament, C ;
Taieb, J ;
Chaput, N ;
Puig, PE ;
Novault, S ;
Escudier, B ;
Vivier, E ;
Lecesne, A ;
Robert, C ;
Blay, JY ;
Bernard, J ;
Caillat-Zucman, S ;
Freitas, A ;
Tursz, T ;
Wagner-Ballon, O ;
Capron, C ;
Vainchencker, W ;
Martin, F ;
Zitvogel, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) :1075-1085
[27]   CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets [J].
Gleason, Michelle K. ;
Ross, Julie A. ;
Warlick, Erica D. ;
Lund, Troy C. ;
Verneris, Michael R. ;
Wiernik, Andres ;
Spellman, Stephen ;
Haagenson, Michael D. ;
Lenvik, Alexander J. ;
Litzow, Mark R. ;
Epling-Burnette, Pearlie K. ;
Blazar, Bruce R. ;
Weiner, Louis M. ;
Weisdorf, Daniel J. ;
Vallera, Daniel A. ;
Miller, Jeffrey S. .
BLOOD, 2014, 123 (19) :3016-3026
[28]   Bispecific and Trispecific Killer Cell Engagers Directly Activate Human NK Cells through CD16 Signaling and Induce Cytotoxicity and Cytokine Production [J].
Gleason, Michelle K. ;
Verneris, Michael R. ;
Todhunter, Deborah A. ;
Zhang, Bin ;
McCullar, Valarie ;
Zhou, Sophia X. ;
Panoskaltsis-Mortari, Angela ;
Weiner, Louis M. ;
Vallera, Daniel A. ;
Miller, Jeffrey S. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) :2674-2684
[29]   Natural Killer Cell Killing of Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia Blasts by Killer Cell Immunoglobulin-Like Receptor-Negative Natural Killer Cells after NKG2A and LIR-1 Blockade [J].
Godal, Robert ;
Bachanova, Veronika ;
Gleason, Michelle ;
McCullar, Valarie ;
Yun, Gong H. ;
Cooley, Sarah ;
Verneris, Michael R. ;
McGlave, Philip B. ;
Miller, Jeffrey S. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (05) :612-621
[30]   CD56dimCD16+ NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases [J].
Grzywacz, B. ;
Kataria, N. ;
Verneris, M. R. .
LEUKEMIA, 2007, 21 (02) :356-359